Misti Ushio

180 Degree Capital Corp., a business development company listed on Nasdaq, invests in both public and private companies located in the United States. The fund targets companies operating across a broad range of sectors and industries. It makes controlling and non-controlling investments in the form of equity, preferred stock, warrants and debt. It considers co-investments and takes seat on the board of directors.

Senova Systems, Inc. develops and sells technology for measuring pH meters. It provides platform for the life science, food and beverage, dairy, petrochemical, water, and environmental sectors. The firm offers a pHit sensor platform which utilizes a carbon substrate containing proprietary analyte sensing molecules or ASMs. The company was founded by Gil M. Labrucherie, Robert L. Bratzler, Egisto Boschetti, Lee Leonard and Bernard Lemaitre in 2007 and is headquartered in Sunnyvale, CA.

AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC.

Synglyco, Inc. develops novel vaccines using synthetic carbohydrates. The firm's cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications. Its proprietary platform generates significant quantities of chemically pure, complex carbohydrates through automated and manual chemical synthesis. The company was founded by Peter H. Seeberger, Carmichael S. Roberts Jr. Obadiah J. Plante and Louis Schofield on June 18, 2001 and is headquartered in New York, NY.

TARA Biosystems, Inc. develops organ-on-a-chip platform. It focuses on cardiac toxicology, heart failure drug discovery and personalized cardiology. The company was founded by Misti Ushio, Milica Radisic, Yimu Zhao, Gordana Vunjak-Novakovic, Kacey Ronaldson, Boyang Zhang and Blake Stevens on October 22, 2014 and is headquartered in New York, NY.

ProMuc, Inc. develops synthetic mucins for lubrication and antimicrobial applications. The company was founded by Katharina Ribbeck and is headquartered in Cambridge, MA.